Global Health Roundup: Maternity Ward Closures, Early Flu Season, and Vaccine Demand Headline October Health Developments

A wave of maternity ward closures in the United States, an earlier-than-usual flu season in England, and surging demand for the shingles vaccine are among the major health developments emerging Sunday, Oct. 11, 2026, as health systems across the Western world grapple with funding pressures, seasonal disease threats, and evolving public health priorities.

U.S. Maternity Wards Under Pressure

Maternity wards across the United States are facing widespread closures as federal Medicaid funding cuts take effect, according to The Guardian. Analysis by the non-profit organization Protect Our Care found that 52 maternity wards have closed since the HR1 bill – referred to by the Trump administration as the "big, beautiful bill" – was announced in July 2025, with a further eight facilities having announced upcoming closures.

Experts warn the situation is set to worsen. The spending cuts are expected to be fully felt in 2027, but hospitals are already reporting significant financial strain. The closures raise concerns about access to maternal care, particularly in rural and underserved communities where alternative facilities may be limited.

England's Flu Season Arrives Early

In the United Kingdom, health authorities are urging at-risk groups to seek vaccination after flu cases registered above-average levels in England during September, The Guardian reported. The UK Health Security Agency (UKHSA) noted that while flu activity remains at low levels overall, multiple indicators – including the proportion of positive tests, GP consultations for influenza-like illness, and emergency-department attendances – are tracking above seasonally expected levels for this point in the year.

The UKHSA emphasized that vaccination remains the most effective tool for reducing the impact of the flu season, particularly for vulnerable populations.

Shingles Vaccine Demand Driven by Dementia Fears

Demand for the shingles vaccine is rising sharply in Britain, driven in part by growing public concern about dementia rather than the vaccine's primary purpose of preventing painful rashes, according to The Guardian. High street chemists have reported increased uptake, with many patients citing a desire to reduce their dementia risk as a motivating factor. While the vaccine is available free to some patients through the NHS, most individuals under 65 are paying approximately £450 for the full two-dose course.

Experts note that while early signs are promising regarding a potential link between the shingles vaccine and reduced dementia risk, the evidence remains inconclusive.

Additional Health Concerns

Separately, the American Academy of Pediatrics last week called for a ban on the sale of unpasteurized raw milk in the United States, The Guardian reported, citing several recent disease outbreaks linked to the product. Despite the health warnings, the raw milk industry has experienced record growth in recent years. Meanwhile, BBC News highlighted that childhood cancer – though rare – remains the leading cause of death from disease among children under 15 in the United Kingdom, with experts cautioning that symptoms are frequently overlooked or misidentified.

Taken together, Sunday's health developments underscore the mounting pressures facing health systems on both sides of the Atlantic, from structural funding challenges to seasonal disease preparedness and evolving consumer health behaviors.